Market Cap (In USD)
6.4 Million
Revenue (In USD)
4.92 Million
Net Income (In USD)
-5.43 Million
Avg. Volume
89.51 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0101-0.1029
- PE
- -
- EPS
- -
- Beta Value
- 1.82
- ISIN
- US85859W1027
- CUSIP
- 85859W102
- CIK
- 1511820
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Charles S. Arnold
- Employee Count
- -
- Website
- https://www.stemtech.com
- Ipo Date
- 2021-11-26
- Details
- Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its dietary supplement products under the RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze brands. The company is based in Miramar, Florida.
More Stocks
-
NTR-BNTR Holding A/S
NTR-B
-
BCCEF
-
EUDA
-
688718
-
BRAXFBraxia Scientific Corp.
BRAXF
-
3305
-
KERALAYURKerala Ayurveda Limited
KERALAYUR
-
CIO-PACity Office REIT, Inc.
CIO-PA